Position Statements

The American College of Rheumatology position statements are official statements that reflect the position of the College on issues related to the management of rheumatic and musculoskeletal conditions.

The existing ACR statements are updated every four years or when circumstances dictate an earlier review and update. These papers serve as a trusted and valuable resource for the health care industry. Looking for more information on health policy? Read our Federal Advocacy Policy Positions.

Access and Coverage

• Access to Care - 02/2017
• Beers List - 08/2018
• Biosimilars - 03/2018
• Complexity of Biologics - 08/2015
• Compounding of Pharmacologic Agents- 02/2017
• FDA Labeling - 12/2015
• Medical Liability Reform - 11/2017
• Medicare Recovery Audit Contractors - 08/2018
• Multidisciplinary Care for Patients with Rheumatic and Musculoskeletal Diseases - 08/2015
• Programs Limiting Copay Assistance - 10/2018
• The Rheumatologist as Principal Care Physician - 08/2015
• Viscosupplementation - 02/2014

Research

• Comparative Effectiveness Research - 08/2017
• Complementary and Alternative Therapies for Rheumatic Disease - 2016
• Use of Animals in Biomedical Research - 08/2015

Role of Rheumatology

• Bone Density Measurement and the Role of Rheumatologists in Osteoporosis - 08/2017
• Use of Diagnostic Imaging in Rheumatology Practice - 08/2018
• Maintenance of Certification - 08/2015
• Musculoskeletal Ultrasound - 08/2018
• Referral Guidelines - 08/2015
• Synovial Fluid Crystal Analysis - 02/2014

Treatment

• Clinical Laboratory Testing - 11/2017
• Methodology of Testing Antinuclear Antibodies - 08/2015
• Patient Access to Biologics - 08/2015
• Patient Safety and Site of Service for Infusible Biologics - 02/2017
• Pharmacovigilance - 05/2018
• Screening for Hydroxychloroquine Retinopathy - 08/2016
• Step Edit Therapies - 08/2013
• Therapeutic Substitution - 08/2015